Jiangxi Institute of Biological Products says stabilizing manager buys 5,435,000 H shares at HK$7.4-HK$10.46

• Stabilization period for the global offering ended on July 25, 2026.
• Stabilizing manager over-allocated 5,435,000 H shares in the international offering, about 15% of initial offer shares.
• Successive on-market purchases totaled 5,435,000 H shares at HK$ 7.4 to HK$ 10.46 to cover the over-allocation.
• Last stabilizing purchase was on June 30, 2026 at HK$ 9.78 per H share.
• Over-allotment option was not exercised and lapsed on July 25, 2026; no H shares will be issued under it.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Institute of Biological Products Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260726-12256625), on July 26, 2026, and is solely responsible for the information contained therein.